{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:42:57Z","timestamp":1778035377103,"version":"3.51.4"},"reference-count":61,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T00:00:00Z","timestamp":1676678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Invasive fungal infections (IFIs) are frequent and outcome-relevant complications in the early postoperative period after orthotopic liver transplantation (OLT). Recent guidelines recommend targeted antimycotic prophylaxis (TAP) for high-risk liver transplant recipients (HR-LTRs). However, the choice of antimycotic agent is still a subject of discussion. Echinocandins are increasingly being used due to their advantageous safety profile and the increasing number of non-albicans Candida infections. However, the evidence justifying their use remains rather sparse. Recently published data on breakthrough IFI (b-IFI) raise concerns about echinocandin efficacy, especially in the case of intra-abdominal candidiasis (IAC), which is the most common infection site after OLT. In this retrospective study, we analyzed 100 adult HR-LTRs undergoing first-time OLT and receiving echinocandin prophylaxis between 2017 and 2020 in a tertiary university hospital. We found a breakthrough incidence of 16%, having a significant impact on postoperative complications, graft survival, and mortality. The reasons for this may be multifactorial. Among the pathogen-related factors, we identified the breakthrough of Candida parapsilosis in 11% of patients and one case of persistent IFI due to the development of a secondary echinocandin resistance of an IAC caused by Candida glabrata. Consequently, the efficacy of echinocandin prophylaxis in liver transplantation should be questioned. Further studies are necessary to clarify the matter of breakthrough infections under echinocandin prophylaxis.<\/jats:p>","DOI":"10.3390\/jof9020272","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T02:56:02Z","timestamp":1676861762000},"page":"272","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Invasive Fungal Breakthrough Infections under Targeted Echinocandin Prophylaxis in High-Risk Liver Transplant Recipients"],"prefix":"10.3390","volume":"9","author":[{"given":"Robert","family":"Breitkopf","sequence":"first","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care Medicine, Medical University Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3648-7338","authenticated-orcid":false,"given":"Benedikt","family":"Treml","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care Medicine, Medical University Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5711-244X","authenticated-orcid":false,"given":"Thomas","family":"Senoner","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care Medicine, Medical University Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoran","family":"Bukumiri\u0107","sequence":"additional","affiliation":[{"name":"Institute of Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6193-3662","authenticated-orcid":false,"given":"Sasa","family":"Rajsic","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care Medicine, Medical University Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Scolarici, M., Jorgenson, M., Saddler, C., and Smith, J. (2021). Fungal Infections in Liver Transplant Recipients. J. Fungi, 7.","DOI":"10.3390\/jof7070524"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00007890-200201150-00011","article-title":"Trends in Invasive Fungal Infections in Liver Transplant Recipients: Correlation with Evolution in Transplantation Practices","volume":"73","author":"Singh","year":"2002","journal-title":"Transplantation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/13693780701200372","article-title":"Fungal Infections in Solid Organ Transplantation","volume":"45","author":"Silveira","year":"2007","journal-title":"Med. Mycol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"E454","DOI":"10.1111\/ctr.12129","article-title":"Fungal Infections after Liver Transplantation: Outcomes and Risk Factors Revisited in the MELD Era","volume":"27","author":"Saliba","year":"2013","journal-title":"Clin. Transpl."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0891-5520(02)00067-3","article-title":"Fungal Infections in the Recipients of Solid Organ Transplantation","volume":"17","author":"Singh","year":"2003","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/clind\/16.5.677","article-title":"Fungal Infections in Solid-Organ Transplantation","volume":"16","author":"Paya","year":"1993","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1469-0691.12641","article-title":"Invasive Fungal Infections in Solid Organ Transplant Recipients","volume":"20","author":"Meije","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/lt.24032","article-title":"Invasive Aspergillosis in Liver Transplant Recipients: Epidemiology, Clinical Characteristics, Treatment, and Outcomes in 116 Cases","volume":"21","author":"Barchiesi","year":"2015","journal-title":"Liver Transpl."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jiac.2015.11.005","article-title":"Epidemiology of Invasive Fungal Infections after Liver Transplantation and the Risk Factors of Late-Onset Invasive Aspergillosis","volume":"22","author":"Nagao","year":"2016","journal-title":"J. Infect. Chemother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1590\/S0074-02762011000300014","article-title":"Epidemiology of Fungal Infections in Liver Transplant Recipients: A Six-Year Study of a Large Brazilian Liver Transplantation Centre","volume":"106","author":"Zicker","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1399-3062.2010.00492.x","article-title":"Epidemiology and Outcome of Invasive Fungal Infections in Solid Organ Transplant Recipients","volume":"12","author":"Neofytos","year":"2010","journal-title":"Transpl. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1399-3062.2011.00640.x","article-title":"Incidence and Risk Factors for Infections after Liver Transplant: Single-Center Experience at the University Hospital Fundaci\u00f3n Santa Fe de Bogot\u00e1, Colombia","volume":"13","author":"Vera","year":"2011","journal-title":"Transpl. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/lt.23467","article-title":"Invasive Fungal Infections Following Liver Transplantation: Incidence, Risk Factors, Survival, and Impact of Fluconazole-Resistant Candida parapsilosis (2003\u20132007)","volume":"18","author":"Raghuram","year":"2012","journal-title":"Liver Transpl."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.12659\/AOT.881989","article-title":"Invasive Fungal Infections Following Liver Transplantation\u2014Risk Factors, Incidence and Outcome","volume":"16","author":"Pacholczyk","year":"2011","journal-title":"Ann. Transpl."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1097\/00007890-200006270-00016","article-title":"Human Herpesvirus-6 in Liver Transplant Recipients: Role in Pathogenesis of Fungal Infections, Neurologic Complications, and Outcome","volume":"69","author":"Rogers","year":"2000","journal-title":"Transplantation"},{"key":"ref_16","first-page":"38","article-title":"Fungal Infections Complicating Orthotopic Liver Transplantation","volume":"106","author":"Karchmer","year":"1995","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/ajt.16935","article-title":"Risk Factors of Invasive Fungal Infections in Liver Transplant Recipients: A Systematic Review and Meta-Analysis","volume":"22","author":"Phoompoung","year":"2022","journal-title":"Am. J. Transpl."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1097\/01.TP.0000065178.93741.72","article-title":"Changes in the Spectrum and Risk Factors for Invasive Candidiasis in Liver Transplant Recipients: Prospective, Multicenter, Case-Controlled Study","volume":"75","author":"Husain","year":"2003","journal-title":"Transplantation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/ajt.12993","article-title":"Targeted versus Universal Antifungal Prophylaxis Among Liver Transplant Recipients","volume":"15","author":"Eschenauer","year":"2015","journal-title":"Am. J. Transpl."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/lt.20690","article-title":"Antifungal Prophylaxis in Liver Transplant Patients: A Systematic Review and Meta-Analysis","volume":"12","author":"Cruciani","year":"2006","journal-title":"Liver Transpl."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1111\/ajt.12925","article-title":"Antifungal Prophylaxis in Liver Transplantation: A Systematic Review and Network Meta-Analysis","volume":"14","author":"Evans","year":"2014","journal-title":"Am. J. Transpl."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e13544","DOI":"10.1111\/ctr.13544","article-title":"Invasive Aspergillosis in Solid-Organ Transplant Recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Husain","year":"2019","journal-title":"Clin. Transpl."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e13623","DOI":"10.1111\/ctr.13623","article-title":"Candida Infections in Solid Organ Transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Aslam","year":"2019","journal-title":"Clin. Transpl."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00134-014-3408-3","article-title":"Worrisome Trends in Incidence and Mortality of Candidemia in Intensive Care Units (Paris Area, 2002\u20132010)","volume":"40","author":"Lortholary","year":"2014","journal-title":"Intensive Care Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/archsurg.1997.01430350047008","article-title":"Emerging Evidence of Selection of Fluconazole-Tolerant Fungi in Surgical Intensive Care Units","volume":"132","author":"Gleason","year":"1997","journal-title":"Arch. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0002-9343(95)00010-0","article-title":"The Changing Face of Candidemia: Emergence of Non-Candida Albicans Species and Antifungal Resistance","volume":"100","author":"Nguyen","year":"1996","journal-title":"Am. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/archsurg.135.2.160","article-title":"Effects of Fluconazole Administration in Critically Ill Patients: Analysis of Bacterial and Fungal Resistance","volume":"135","author":"Rocco","year":"2000","journal-title":"Arch. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1600-6143.2007.02089.x","article-title":"Antifungal Management Practices in Liver Transplant Recipients","volume":"8","author":"Singh","year":"2008","journal-title":"Am. J. Transpl."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1111\/j.1600-6143.2009.02909.x","article-title":"Candida in Solid Organ Transplant Recipients","volume":"9","author":"Pappas","year":"2009","journal-title":"Am. J. Transpl."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1111\/j.1600-6143.2009.02910.x","article-title":"Invasive Aspergillosis in Solid Organ Transplant Recipients","volume":"9","author":"Singh","year":"2009","journal-title":"Am. J. Transpl."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/cid\/ciu1128","article-title":"Randomized Trial of Micafungin for the Prevention of Invasive Fungal Infection in High-Risk Liver Transplant Recipients","volume":"60","author":"Saliba","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID* Guideline for the Diagnosis and Management of Candida Diseases 2012: Non-Neutropenic Adult Patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/2047-783X-16-4-167","article-title":"Treatment and Prophylaxis of Invasive Candidiasis with Anidulafungin, Caspofungin and Micafungin: Review of the Literature","volume":"16","year":"2011","journal-title":"Eur. J. Med. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/11585270-000000000-00000","article-title":"Echinocandin Antifungal Drugs in Fungal Infections: A Comparison","volume":"71","author":"Chen","year":"2011","journal-title":"Drugs"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/tcrm.2007.3.1.71","article-title":"Comparison of Echinocandin Antifungals","volume":"3","author":"Eschenauer","year":"2007","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1177\/0091270005278601","article-title":"Concomitant Cyclosporine and Micafungin Pharmacokinetics in Healthy Volunteers","volume":"45","author":"Hebert","year":"2005","journal-title":"J. Clin. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1016\/j.transproceed.2010.04.030","article-title":"Micafungin Does Not Influence the Concentration of Tacrolimus in Patients after Allogeneic Hematopoietic Stem Cell Transplantation","volume":"42","author":"Fukuoka","year":"2010","journal-title":"Transpl. Proc."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"831","DOI":"10.5414\/CP201738","article-title":"Drug Interactions between Micafungin at High Doses and Cyclosporine A in Febrile Neutropenia Patients after Allogeneic Hematopoietic Stem Cell Transplantation","volume":"50","author":"Inoue","year":"2012","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1177\/0091270005279274","article-title":"Concomitant Tacrolimus and Micafungin Pharmacokinetics in Healthy Volunteers","volume":"45","author":"Hebert","year":"2005","journal-title":"J. Clin. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s002280000216","article-title":"Influence of Continuous Veno-Venous Haemodiafiltration and Continuous Veno-Venous Haemofiltration on the Pharmacokinetics of Fluconazole","volume":"56","author":"Muhl","year":"2000","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/myc.13508","article-title":"Efficacy of Anti-Fungal Agents for Invasive Fungal Infection Prophylaxis in Liver Transplant Recipients: A Network Meta-Analysis","volume":"65","author":"Liu","year":"2022","journal-title":"Mycoses"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and Update of the Consensus Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Chen","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MCC.0b013e328028fd92","article-title":"Candida Peritonitis","volume":"13","author":"Blot","year":"2007","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1007\/s00134-013-3134-2","article-title":"Intra-Abdominal Candidiasis: The Guidelines\u2014Forgotten Non-Candidemic Invasive Candidiasis","volume":"39","author":"Montravers","year":"2013","journal-title":"Intensive Care Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1007\/s00268-011-1305-2","article-title":"Candida Peritonitis: An Update on the Latest Research and Treatments","volume":"35","author":"Carneiro","year":"2011","journal-title":"World J. Surg."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/myc.12960","article-title":"Defining Breakthrough Invasive Fungal Infection-Position Paper of the Mycoses Study Group Education and Research Consortium and the European Confederation of Medical Mycology","volume":"62","author":"Cornely","year":"2019","journal-title":"Mycoses"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/myc.12170","article-title":"EUCAST Technical Note on Candida and Micafungin, Anidulafungin and Fluconazole","volume":"57","author":"Arendrup","year":"2014","journal-title":"Mycoses"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/TCRM.S882","article-title":"Anidulafungin in the Treatment of Invasive Fungal Infections","volume":"4","author":"Sabol","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e00399-19","DOI":"10.1128\/AAC.00399-19","article-title":"Echinocandins for the Treatment of Invasive Aspergillosis: From Laboratory to Bedside","volume":"63","author":"Aruanno","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_52","unstructured":"Management of Invasive Candidiasis and Aspergillosis in Adults (2004). Conf\u00e9rence de Consensus Commune Organis\u00e9e Conjointement Par La SFAR, La SPILF et La SRLF Avec La Participation de La Soci\u00e9t\u00e9 Fran\u00e7aise D\u2019H\u00e9matologie, de La Soci\u00e9t\u00e9 Fran\u00e7aise de Mycologie M\u00e9dicale et de La Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de M\u0153lle. Rev. Pneumol. Clin., 60, 289\u2013293."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.cmi.2019.05.009","article-title":"Guidelines for Antifungal Therapies in Intensive Care Unit Patients: Not so Bad!","volume":"25","author":"Boyer","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/TP.0000000000003296","article-title":"Clinical Implementation of Prolonged Liver Preservation and Monitoring through Normothermic Machine Perfusion in Liver Transplantation","volume":"104","author":"Cardini","year":"2020","journal-title":"Transplantation"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1586\/17474124.2016.1149061","article-title":"Extended Criteria Donors in Liver Transplantation Part I: Reviewing the Impact of Determining Factors","volume":"10","author":"Nemes","year":"2016","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/tid.12613","article-title":"The Epidemiology and Outcomes of Invasive Candida Infections among Organ Transplant Recipients in the United States: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"18","author":"Andes","year":"2016","journal-title":"Transpl. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.1128\/AAC.04134-14","article-title":"Abdominal Candidiasis Is a Hidden Reservoir of Echinocandin Resistance","volume":"58","author":"Shields","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive Candidiasis","volume":"373","author":"Kullberg","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/lt.21826","article-title":"Antifungal Prophylaxis in Liver Transplant Recipients","volume":"15","author":"Eschenauer","year":"2009","journal-title":"Liver Transplant."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e01009-17","DOI":"10.1128\/AAC.01009-17","article-title":"Unraveling Drug Penetration of Echinocandin Antifungals at the Site of Infection in an Intra-Abdominal Abscess Model","volume":"61","author":"Zhao","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2165\/11592900-000000000-00000","article-title":"Penetration of Anti-Infective Agents into Pulmonaryepithelial Lining Fluid: Focus on Antifungal, Antitubercular and Miscellaneous Anti-Infective Agents","volume":"50","author":"Rodvold","year":"2011","journal-title":"Clin. Pharmacokinet."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/9\/2\/272\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:35:56Z","timestamp":1760121356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/9\/2\/272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,18]]},"references-count":61,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["jof9020272"],"URL":"https:\/\/doi.org\/10.3390\/jof9020272","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,18]]}}}